We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VOXR:NASDAQVox Royalty Corp. Analysis

Data as of 2026-05-09 - not real-time

$5.95

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is showing bullish momentum on the technical side, with the MACD line comfortably above its signal line and an RSI sitting in the upper‑mid range, suggesting continued buying pressure without being overbought. Price action is hovering near a well‑defined resistance while holding above a clear support zone, and the overall trend remains neutral despite a volatility profile that is notably high and a beta that exceeds the market average, reflecting pronounced price swings in a market environment marked by extreme greed.
Fundamentally, the company delivers exceptionally high profit margins and a royalty‑driven revenue model that has accelerated growth, yet valuation metrics are elevated, with a price‑to‑earnings multiple far above peers and a discounted cash‑flow estimate that sits below the current market price. The dividend yield is modest and the payout ratio is only half of earnings, but free cash flow is negative, tempering confidence in long‑term sustainability. Analyst sentiment leans strongly toward a buy, citing upside potential, but the premium pricing and cash flow constraints warrant caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD crossover
  • RSI indicating strong but not overbought momentum
  • Price near resistance with stable volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust royalty revenue growth
  • High profit margins and strong operating cash flow
  • Analyst consensus of strong‑buy with upside potential

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Diversified geographic royalty portfolio
  • Dividend yield providing modest income
  • Overvaluation and negative free cash flow limiting upside

Key Metrics & Analysis

Financial Health

Revenue Growth154.00%
Profit Margin35.41%
P/E Ratio59.5
ROE7.84%
ROA1.13%
Debt/Equity6.26
P/B Ratio3.8
Op. Cash Flow$10.7M
Free Cash Flow$-6442750

Technical Analysis

TrendNeutral
RSI64.1
Support$5.09
Resistance$6.23
MA 20$5.52
MA 50$5.53
MA 200$4.67
MACDBullish
VolumeStable
Fear & Greed Index90.73

Valuation

Fair Value$4.00
Target Price$7.10
Upside/Downside19.33%
GradeOvervalued
TypeGrowth
Dividend Yield1.03%

Risk Assessment

Beta1.36
Volatility47.26%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.